CA2007499C - Treatment methods and vaccines for stimulating an immune response - Google Patents
Treatment methods and vaccines for stimulating an immune response Download PDFInfo
- Publication number
- CA2007499C CA2007499C CA002007499A CA2007499A CA2007499C CA 2007499 C CA2007499 C CA 2007499C CA 002007499 A CA002007499 A CA 002007499A CA 2007499 A CA2007499 A CA 2007499A CA 2007499 C CA2007499 C CA 2007499C
- Authority
- CA
- Canada
- Prior art keywords
- virus
- blood
- patient
- treated
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
- A61L2/18—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2103/00—Materials or objects being the target of disinfection or sterilisation
- A61L2103/05—Living organisms or biological materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US295,454 | 1981-08-24 | ||
| US07/295,454 US4960408A (en) | 1989-01-10 | 1989-01-10 | Treatment methods and vaccines for stimulating an immunological response against retroviruses |
| US36406389A | 1989-06-08 | 1989-06-08 | |
| US364,063 | 1989-06-08 | ||
| US46081190A | 1990-01-04 | 1990-01-04 | |
| US460,811 | 1990-01-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2007499A1 CA2007499A1 (en) | 1990-07-10 |
| CA2007499C true CA2007499C (en) | 2001-03-27 |
Family
ID=27404363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002007499A Expired - Fee Related CA2007499C (en) | 1989-01-10 | 1990-01-10 | Treatment methods and vaccines for stimulating an immune response |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0453497A4 (de) |
| JP (1) | JPH04502621A (de) |
| AU (1) | AU638693B2 (de) |
| BR (1) | BR9007016A (de) |
| CA (1) | CA2007499C (de) |
| FI (1) | FI105453B (de) |
| HU (1) | HUT62487A (de) |
| IL (1) | IL92996A (de) |
| WO (1) | WO1990007952A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120649A (en) * | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
| US6433343B1 (en) | 1992-03-02 | 2002-08-13 | Cerus Corporation | Device and method for photoactivation |
| FR2694886A1 (fr) * | 1992-08-06 | 1994-02-25 | Zaki George | Procédé et dispositif pour stériliser le sang des malades du sida, de la malaria ou d'une autre maladie bactérienne, parasitaire ou virale du sang. |
| FR2698270B1 (fr) * | 1992-11-20 | 1995-01-13 | Goupil Jean Jacques | Utilisation du 5-méthoxypsoralène dans le traitement du sida. |
| EP0727938B1 (de) * | 1993-11-10 | 2003-06-18 | Cerus Corporation | Vorrichtung und verfahren zur photoaktivierung |
| WO1996008965A1 (en) * | 1994-09-22 | 1996-03-28 | Baxter International, Inc. | Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
| DE19914850A1 (de) * | 1999-04-01 | 2000-10-05 | Gerhard Saalmann | Vorrichtung und Verfahren zur Inaktivierung von Viren in biologischen Flüssigkeiten |
| US20030108543A1 (en) * | 2001-12-12 | 2003-06-12 | Lewandowski Leon J. | Photophoretic auto immune stimulation |
| WO2004084936A2 (en) * | 2003-02-06 | 2004-10-07 | Cerus Corporation | Modified free-living microbes, vaccine compositions and methods of use thereof |
| US20080102505A1 (en) * | 2006-09-18 | 2008-05-01 | Petrie Thomas R Jr | Method of treating viral infections with ultraviolet light |
| GB2509940A (en) * | 2013-01-18 | 2014-07-23 | John Ogino | Vaccine production via irradiation of pathogenic cultures |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321919A (en) * | 1979-12-11 | 1982-03-30 | Leukocyte Research, Inc. | Method and system for externally treating human blood |
| US4568542A (en) * | 1981-06-09 | 1986-02-04 | Lee Biomolecular Research Laboratories, Inc. | Vaccine compositions |
| US4464166A (en) * | 1981-06-12 | 1984-08-07 | Frederic A. Bourke, Jr. | Method for externally treating the blood |
| DE3483751D1 (de) * | 1983-05-02 | 1991-01-31 | Diamond Scient Co | Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen. |
| DK507185A (da) * | 1984-11-05 | 1986-05-06 | Du Pont | Fremgangsmaade til inaktivering af human tumor leukaemi virus iii |
| US4838852A (en) * | 1987-03-27 | 1989-06-13 | Therakos, Inc. | Active specific immune suppression |
-
1990
- 1990-01-08 IL IL9299690A patent/IL92996A/en not_active IP Right Cessation
- 1990-01-10 JP JP2502474A patent/JPH04502621A/ja active Pending
- 1990-01-10 BR BR909007016A patent/BR9007016A/pt unknown
- 1990-01-10 AU AU49545/90A patent/AU638693B2/en not_active Ceased
- 1990-01-10 HU HU912326A patent/HUT62487A/hu unknown
- 1990-01-10 CA CA002007499A patent/CA2007499C/en not_active Expired - Fee Related
- 1990-01-10 WO PCT/US1990/000275 patent/WO1990007952A1/en not_active Ceased
- 1990-01-10 EP EP19900902445 patent/EP0453497A4/en not_active Withdrawn
-
1991
- 1991-07-09 FI FI913318A patent/FI105453B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| IL92996A (en) | 1996-06-18 |
| BR9007016A (pt) | 1991-11-12 |
| EP0453497A1 (de) | 1991-10-30 |
| HUT62487A (en) | 1993-05-28 |
| WO1990007952A1 (en) | 1990-07-26 |
| FI913318A0 (fi) | 1991-07-09 |
| EP0453497A4 (en) | 1992-10-07 |
| FI105453B (fi) | 2000-08-31 |
| AU4954590A (en) | 1990-08-13 |
| AU638693B2 (en) | 1993-07-08 |
| JPH04502621A (ja) | 1992-05-14 |
| CA2007499A1 (en) | 1990-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4960408A (en) | Treatment methods and vaccines for stimulating an immunological response against retroviruses | |
| CA1306678C (en) | Active specific immune suppression | |
| US8506968B2 (en) | SARS vaccine compositions and methods of making and using them | |
| US20090028902A1 (en) | Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases | |
| CA2007499C (en) | Treatment methods and vaccines for stimulating an immune response | |
| DE69734450T2 (de) | Photopherese-behandlung von hcv-infektionen | |
| US20080220016A1 (en) | Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties | |
| EP0101200A2 (de) | Transferfaktor zur Anwendung in der Behandlung von Virusinfektionen | |
| RU2207876C1 (ru) | Способ комплексно-индивидуализированного воздействия на организм при медленной вирусной инфекции и способ подготовки лабораторного животного для испытания способа такого воздействия | |
| CA2529965C (en) | Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases | |
| WO1989005657A1 (en) | Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection | |
| JP2004506015A (ja) | レトロウイルス免疫療法 | |
| US7439052B2 (en) | Method of making modified immunodeficiency virus particles | |
| WO1989009229A1 (en) | Treatment of hiv viremic patients with thymopentin | |
| US20030035813A1 (en) | Immunological treatment methods and agents | |
| AU2008201523B2 (en) | Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases | |
| Wahren | Immunotherapy in Friend virus leukemia. I. Prevention of Friend leukemia in the offspring of immunized mothers | |
| AU2004264842A1 (en) | Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases | |
| GB2269318A (en) | Preventative treatment for AIDS | |
| MXPA98008019A (en) | Treatment for photoferesis of chronic infections for hepatiti viruses | |
| KR20020063153A (ko) | 타인의 면역시스템을 이용하는 에이즈의 치료 방법 | |
| WO1994012212A1 (en) | Human aids vaccine from revertant cattle virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |